from Reuters: Health News https://ift.tt/2J7IF2Q
Thursday, July 12, 2018
Thursday, July 12, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Israeli pharmaceuticals company PainReform has received approval from the U.S. Food and Drug Administration (FDA) to begin late-stage clinical studies for a pain relief drug that is a departure from opiate-based narcotics, it said on Tuesday.

from Reuters: Health News https://ift.tt/2J7IF2Q
from Reuters: Health News https://ift.tt/2J7IF2Q
Related Posts:
LATEST HEALTH NEWSPARIS (Reuters) - Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this… Read More
LATEST HEALTH NEWSBERLIN (Reuters) - Some 6,000 early deaths linked to nitrogen oxides (NOx) are recorded each year in Germany, the Federal Environmental Agency said on Thursday, providing more evidence of the health hazards posed by the toxic… Read More
LATEST HEALTH NEWSPROVIDENCE, R.I. (Reuters) - A Rhode Island doctor was sentenced on Friday to more than four years in prison after admitting he took kickbacks from Insys Therapeutics Inc to prescribe its fentanyl-based cancer pain drug to pe… Read More
LATEST HEALTH NEWS(Reuters Health) - Older adults with heart disease who regularly exercise, even a little bit, may live longer than they would without any physical activity, a Norwegian study suggests. from Reuters: Health News http://if… Read More
LATEST HEALTH NEWSMentioned below are few natural remedies can be an effective aid to fight the inflammatory mechanism of seasonal allergic rhinitis. from Health http://ift.tt/2FuutQn … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment